The largest database of trusted experimental protocols

Pkh26 red fluorescent cell membrane labeling kit

Manufactured by Merck Group
Sourced in United States

The PKH26 red fluorescent cell membrane labeling kit is a laboratory reagent used to label the cell membrane of live cells. It is a lipophilic dye that binds to the lipid regions of the cell membrane, providing a stable red fluorescent label. The kit can be used to track cell movement, monitor cell division, and evaluate cell-cell interactions in various experimental settings.

Automatically generated - may contain errors

4 protocols using pkh26 red fluorescent cell membrane labeling kit

1

Tracking Migratory Fibroblasts in vivo

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fibroblasts were labeled using a PKH26 red fluorescent cell membrane labeling kit (Sigma,
St. Louis, MO, USA) according to manufacturer’s instructions and injected IP into mice.
Mice were euthanized at six time points at 7-day intervals (i.e. week 1 to week 6). Cells
were retrieved from peritoneal cavity (by lavage), lymph nodes, spleen, lung, and skin.
Single cell suspensions form tissues were prepared using collagenase D (Roche Diagnostics)
digestion (1 mg/ mL, for 30 min at 37 °C) and examined using flow cytometry. To further
characterize the cells that were extracted from lymph nodes, these cells were stained for
CD90.2 (eBioscience) and examined using flow cytometry. Presence of migratory fibroblasts
in lymph nodes was examined using confocal microscopy. To do so, PKH26-labeled
IDO-expressing fibroblasts (2 × 107 cells/mouse) were injected IP into C3 H
mice. After 2 weeks, mice were euthanized and mesenteric lymph nodes were harvested,
freshly frozen and embedded in Cryomatrix (Thermo Scientific, Kalamazoo, MI, USA). Frozen
sections (5 μm thick) from lymph nodes were permeabilized with 0.1% Triton-X-100 in
phosphate buffered saline (PBS), stained with 4’,6-diamidino-2-phenylindole (DAPI) and
visualized using a confocal fluorescence microscope (Axio Observer Z1 inverted confocal
with spinning disk, Carl Zeiss, Jena, Germany). Images were analyzed using Zen software
(Carl Zeiss).
+ Open protocol
+ Expand
2

Tracking Migratory Fibroblasts in NOD Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fibroblasts were labeled using PKH26 red fluorescent cell membrane labeling kit (Sigma, St. Louis, MO) according to manufacturer’s instruction and injected to NOD mice intraperitoneally. Mice were euthanized at four time points with 14 days intervals (i.e. week 2 to week 8). Cells were retrieved from peritoneal cavity (by lavage), mesentery, mesenteric lymph nodes, and retro-peritoneal lymph nodes. Single ell suspensions were prepared by collagenase digestion (type I, 1 mg/ mL, Sigma) of tissues. Cells were stained for CCR7, CD90.2 and PD-L1 (eBioscience) and examined using flow cytometry. Further, presence of migratory fibroblasts in lymph nodes was examined using confocal microscopy. T do so, PKH26 labeled control or IDO expressing fibroblasts (2 × 107 cells/ mouse) were injected intraperitoneally to recently diabetic NOD mice. After 2 weeks, mice were euthanized and mesenteric lymph nodes were harvested, freshly frozen and embedded in Cryomatrix (Thermo Scientific). Frozen sections (7 μm thick) from lymph nodes were permeabilized with 0.1% Triton-X-100 in PBS, stained with DAPI and visualized using a confocal fluorescence microscope (Axio Observer Z1 inverted confocal with spinning disk, Carl Zeiss, Jena, Germany). Images were analyzed using Zen software (Zeiss, Jena, Germany).
+ Open protocol
+ Expand
3

Immunofluorescence Analysis of rRAP-1a61-1/CT

Check if the same lab product or an alternative is used in the 5 most similar protocols
An immunofluorescence analysis was performed using a procedure previously described by Moitra et al. [39 (link)] with rabbit antiserum directed against rRAP-1a61-1/CT. The iRBC membrane was stained using a PKH26 red fluorescent cell membrane labeling kit (MINI26, Sigma-Aldrich) according to the manufacturer’s instructions. The iRBCs were fixed in a buffer containing 4 % paraformaldehyde and 10 mM piperazine-N, N-bis (2-ethanesulfonic acid) in PBS (PIPES) at pH 6.4 on 22 mm2 poly-L-lysine-coated coverslips for 30 min at room temperature. The coverslips were washed in PBS and then blocked for 1 h in 3 % bovine serum albumin (BSA) in PBS containing 0.25 % Triton X-100. The coverslips were stained overnight at 4 °C with either pre-immune serum or purified anti-rRAP-1a61-1/CT serum (1:50) diluted in blocking buffer without Triton X-100. The coverslips were washed 3 times in PBS, stained for 1 h with FITC-conjugated anti-rabbit IgG (whole molecule) secondary antibodies (Sigma: F0382; 1:80), and then washed 3 times in PBS. The coverslips were stained with 1 μg/ml 4’,6-diamidino-2-phenylindole (DAPI) (Sigma: D8417) for 10 min and then examined for reactivity using confocal microscopy.
+ Open protocol
+ Expand
4

Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human UCB was collected from the umbilical vein after neonatal delivery, and human UCB-derived MSCs were prepared according to the proper manufacturing practices at MEDIPOST Co., Ltd.(Seoul Korea). Mother was provided informed consent. UCB collection and MSC isolation of from UCB were approved by the Institutional Review Board of MEDIPOST Co., LTD. In the present study, we used MSCs from single donor to avoid donor related variation. Cell quality control and quality assurance tests were conducted in accordance with KFDA standards. MSCs were cultivated as previously described [10 (link), 11 (link)] and additional details are described in our previous reports [5 (link)–7 (link), 12 (link)]. Before transplantation human UCB-derived MSCs (fifth passage, single donor) were labeled using a PKH26 Red Fluorescent Cell Membrane Labeling Kit (Sigma-Aldrich, St. Louis, MO, USA) according to the manufacturer protocol. On P5, a single dose of human UCB-derived MSCs was administered either intratracheally (5 × 105 cells) or intravenously (2 × 106 cells) via the right jugular vein. Transplantation timing referred to our previous study. Transplantation timing was based upon our previous study [5 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!